002370 亚太药业
2024/09 - 九个月
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--00033,454
投资性房地产620-4.02%64612,33300
固定资产344,272-5.62%364,755384,499430,506443,309
在建工程9792,779.41%34090144,437
无形资产54,913-7.25%59,20657,22251,57249,949
商誉0--0000
其他非流动资产52,6866.32%49,55364,977131,952110,333
453,469-4.37%474,193519,030614,933681,483

流动资产
货币资金689,104-4.35%720,475757,617821,113902,935
应收账款80,2150.89%79,51089,05969,964117,642
存货69,367-22.47%89,47595,20560,89964,877
其他流动资产65,8690.23%65,72162,96543,872189,384
904,555-5.30%955,1801,004,845995,8491,274,838

流动负债
短期借款0-100.00%50,06050,06100
应付票据0-100.00%2,32030,37000
应付帐款34,906-29.45%49,47759,46153,92644,955
其他流动负债651,219986.32%59,94782,491160,224246,564
686,125324.05%161,803222,383214,150291,519
流动资产净值218,429-72.47%793,377782,462781,699983,319
资产总额减流动负债671,899-46.99%1,267,5711,301,4921,396,6311,664,802

非流动负债
长期借款0--000110,160
应付债券0-100.00%639,477900,015861,581820,279
其他非流动负债46,472-1.58%47,220100,211102,08973,954
46,472-93.23%686,6961,000,226963,6701,004,393

总权益
    实收股本625,2442.64%609,171536,687536,618536,558
    储备项目182-100.64%(28,297)(235,420)(103,657)123,851
股东权益625,4277.67%580,874301,267432,962660,409
非控股权益0--0000